Investigation of keratinocyte differentiation and proliferation markers by HASH(0x7fe9883ac928)
- k i i -
üb s a S'A 
INVESTIGATION OF KERATINOCYTE DIFFERENTIATION AND 
PROLIFERATION MARKERS 
PhD Dissertation 
Andor Pivarcsi 
2001 
lh S'USA 
INVESTIGATION OF KERATINOCYTE DIFFERENTIATION AND 
PROLIFERATION MARKERS 
PhD Dissertation 
Andor Pivarcsi 
University of Szeged, Faculty of Medicine, Albert Szent-Györgyi Medical and 
Pharmaceutical Center, Department of Dermatology 
CONTENTS 
List of publications 2 
1. Introduction 4 
1.1 Proliferation and differentiation markers in the epidermis 4 
1.2 The skin and the innate immune system 7 
2. Aims 9 
3. Materials and Methods 
3.1 Cells 10 
3.1.1 Separation of human epidermal keratinocytes 10 
3.1.2 Culturing of normal human epidermal keratinocytes 10 
3.1.3 Culturing of HaCaT keratinocytes 10 
3.2 Synchronization procedure 11 
3.3 Immunocytochemical analyzes 11 
3.3.1 Immunocytochemistry on cultured HaCaT keratinocytes 11 
3.3.2 Immunocytochemistry on cultured human epidermal melanocytes 12 
3.3.3 Immunocytochemistry on cultured human keratinocytes 12 
3.4 Western blot analyzes 13 
3.5 Propidium iodide (PI) DNA analyzes 13 
3.6 Flow cytometric analyzes of separated epidermal keratinocytes 14 
3.7 Reverse transcription polymerase chain reaction (RT-PCR) 14 
3.8 Silver staining of proteins in SDS polyacrylamide gel 15 
4. Results 
4.1 Expression of keratin 1 and keratin 10 correlates with the proliferation 
of HaCaT keratinocytes 17 
4.1.1 Expression of a5 integrin in HaCaT keratinocytes is regulated 
by environmental conditions 17 
4.1.2 HaCaT keratinocytes lose K1/K10 expression after release from 
synchronized state 20 
4.1.3 a5 integrin mRNA and protein expression increase while keratin 1 and 10 
mRNAs and protein decrease with proliferation in HaCaT keratinocytes... 22 
4.1.4 The roles of cyclin D1 and D2 are different in human keratinocytes 23 
4.1.5 Expression of cyclin D1 and D2 in cultured human epidermal melanocytes.. 24 
4.2 Serum factors regulate the expression of keratin 1 and a5 integrin 
genes but not the keratin 10 gene n HaCaT keratinocytes 26 
4.3 Further characterization of the mannose binding receptors expressed on 
suprabasal human keratinocytes 28 
4.3.1 Flow cytometric detection of mannose receptors on the surface of 
separated epidermal keratinocytes 28 
4.3.2 Western blot analyzes of the keratinocyte mannose binding receptor 29 
4.3.3 Silver staining of affinity purified keratinocyte mannose receptor 30 
5.Discussio n 31 
6.Summary 37 
7. References 38 
8. Acknowledgments 47 
2 
List of publications 
I. Dithranol hatása humán keratinociták citokin expressziójára 
Farkas Árpád, Kemény Lajos, Szőny Barnabás József, Bata Zsuzsanna, Kiss Mária, 
Pivarcsi Andor, Dobozy Attila 
Bőrgyógy Vener. Szle. 76(2):55-60,2000 
n. Histidine Decarboxylase Expression in Human Melanoma 
Haak-Frendscho M, Darvas ZS, Hegyesi H, Kárpáti S, Hoffinan RL, Laszlo V, 
Bencsath M, Szalai C, Furesz J, Timar J, Bata-Csorgo ZS, Szabad G, Pivarcsi A, 
Paliinger E, Kemeny L, Horváth A, Dobozy A, Falus A 
J. Invest. Dermatol. 115(3):345-352,2000. 
HI. Dithranol upregulates IL-10 recetors on the cultured human keratinocyte cell line 
HaCaT 
Árpád Farkas, Lajos Kemény, Barnabás József Szőny, Zsuzsanna Bata-Csörgő, Andor 
Pivarcsi, Márta Széli, Andrea Koreck, Attila Dobozy 
Inflammation Res. 50 (2001) pp. 43-48 
Accepted for publication: 
IV. Serum factors regulate the expression of the proliferation related genes a5 
integrin and keratin 1 but not keratin 10 in HaCaT keratinocytes 
Andor Pivarsi, Márta Széli, Lajos Kemény, Attila Dobozy and Zsuzsanna Bata-Csörgő 
Arch. Dermatol. Res. In press. 
3 
V. A Mannose-binding Receptor is expressed on human Keratinocytes and Mediates 
Killing of Candida albicans 
Győző Szolnoky, Zsuzsanna Bata-Csörgő, Anna Sz. Kenderessy, Mária Kiss, Andor 
Pivarcsi, Zoltán Nóvák, Katalin Nagy Newman, Günter Michel, Thomas Ruzicka, 
László Maródi, Attila Dobozy and Lajos Kemény 
J. Invest Dermatol. In press. 
4 
1. INTRODUCTION 
The epidermis, the outermost skin layer, provides the first line of defense against the 
external environment. The major cell type in epidermis and the cell type responsible for 
constructing the protective barrier is the epidermal keratinocyte [1,2,3]. Keratinocyte 
differentiation is the process whereby a relatively undifferentiated keratinocyte is converted 
into a suprabasal transiently amplifying cell (TAC) and finally into a corneocyte. The 
different populations of differentiating epidermal keratinocytes are characterized by 
expression of specific markers and they are functionally distinct. The transition from a basal 
cell to a corneocyte is a complex process that requires the simultaneous activation and 
inactivation of a wide variety of genes. Although it is unclear what mechanisms regulate the 
exit from cell cycle into senescence in keratinocytes, both the functional down-regulation of 
integrins and the expression of certain types of keratins (e.g. keratins 1 and 10 (K1/K10)) 
seem to be involved in this fundamental step in the differentiation program [4,5,6], A major 
goal of keratinocyte-related research is to identify the mechanisms that regulate these 
processes. 
1.1 Proliferation and differentiation markers in the epidermis 
While most stages of squamous differentiation are well characterized, including 
changes in gene expression, factors that regulate the induction and repression of genes remain 
largely unknown. Integrins and keratins are two major groups of proteins that are closely 
related to keratinocyte proliferation and differentiation [4,6,7,8,9,10], Basal keratinocytes 
contain several integrins, the proteins that recognize extracellular matrix components. 
Integrins are transembrane proteins composed of one a- and one P-subunit. The particular aP 
combination determines the specificity of binding of an integrin to its extracellular matrix 
protein ligand. Keratinocyte integrins a2Pi, a3Pi, a5Pi, 0^4 and OvPs, are receptors for 
collagen, laminin, fibronectin, kalinin and vitronectin, respectively. 
a5 integrin is poorly expressed in normal skin but in highly proliferative skin such as 
foetal epidermis, wounded skin and in psoriasis its expression is up-regulated [11,12,13,14]. 
In all cases, a5 integrin is expressed only in undifferentiated keratinocytes and it is lost from 
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the cell surface as keratinocytes differentiate [4,5,10], Recent evidences suggest that integrins 
function not only as adhesive proteins but also as receptors capable of transducing 
biochemical signals to the interior of the cell [15]. Fibronectin through its main receptor, 
a5(31 integrin, can provide anchorage-independent direct cell cycle regulatory signals [16] by 
the direct modulation of cyclin-dependent kinase activity [17], Chen et al. showed that 
integrin mediated cell adhesion activates mitogen activated protein kinases (MAP kinases) 
[18]. In ex vivo keratinocyte culture anti-a5 integrin monoclonal antibody inhibits the growth 
of already adhered keratinocytes on fibronectin [19]. 
The commonly used phenotypic markers of epithelial development and differentiation 
are keratins, a large family of approximately 30 proteins that form the intermediate filament 
network in all epithelial cells [20]. The most prominent proteins specific to basal cells are 
keratins 5 and 14. Keratins 1 and 10 are expressed in differentiating keratinocytes, while 
keratins 6 and 16 are expressed in activated keratinocytes [21], Keratin genes are not 
dispersed through the genome but clustered in linkage groups [22], 
For a long time it was thought that K1/K10 keratins have only structural role in the 
cells. More recent data suggest that in addition to providing mechanical integrity to the cells 
in the context of a tissue, keratins also participate in signaling processes fundamental for cell 
physiology [23], Ectopic expression of K10 has been shown to inhibit the proliferation of 
HaCaT keratinocytes [23], although in the in vivo epidermis keratinocytes in the immediate 
suprabasal compartment (that already express K1/K10) can still proliferate (Kl/K10+ 
transiently amplifying keratinocytes) [24], 
Progression through G1 phase to the DNA synthesis (S) phase of the mammalian cell 
cycle is controlled by D-type (Dl, D2 and D3) cyclins in conjunction with their catalytic 
partners, cyclin-dependent kinase 4 (CDK4) and CDK6 [25], One well-appreciated role of 
cyclin D-dependent kinases is to trigger the phosphorylation of the retinoblastoma protein, 
thereby helping to cancel its Gl-specific growth-suppressive function [26,27]. Cyclin D is 
identified as the point at which growth factors act on cell cycle regulation [25]. In their 
monomelic states, CDK subunits are inactive and their catalytic activity depends on cyclin 
binding [28]. Abnormalities in cell cycle regulating mechanism such as increased activity of 
cyclin-CDK due to mutation of p53 protein and overexpression of cyclin D in both human 
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squamous cell carcinoma of the skin and experimentally produced SCC originating from 
mouse keratinocytes (KC) have been reported [29-33], Forced expression of cyclin D1 in 
epithelial tissues of transgenic mice results in epidermal hyperproliferation. This fact suggest 
that cyclin D1 can modulate epithelial proliferation [34], Miracco et al. showed that the 
expression of cyclin D1 decreases after cyclosporin treatment of the hypeiproliferative skin 
disease, psoriasis [35], In mammals three types of D-types cyclins exist that are named cyclin 
Dl, D2 and D3 that share an average of 57% identity over the entire coding region and 78% 
in the cyclin box. Since growth factor regulated expression of the D-type cyclins varies in 
different cell types [25], D-type cyclins may play different functional roles in various cell 
types by responding to different signal transduction pathways. In mitogenically stimulated 
peripherial T cells, cyclins D2 and D3, but not Dl are induced during G1 transition. In 
contrast with this, in macrophages stimulated to enter the cell cycle with colony-stimulating 
factor 1, cyclins Dl and D2 but not D3 are produced during G1 phase. Thus different D-type 
cyclins are likely to be not redundant, but to play distinct roles in mammalian cells. Although 
both Dl and D2 cyclins are expressed in normal human keratinocytes and in the non-
tumorigenic HaCaT keratinocyte cell line, the specific roles for Dl and D2 type cyclins in 
keratinocytes remain unknown. 
HaCaT cells, although immortalized and genetically abnormal, are considered to be 
good models for human keratinocytes [36,37], therefore they are commonly used in 
experiments examining effects of therapeutic drugs on keratinocyte physiology and studying 
keratinocyte biology [23,38,39,40]. HaCaT cells form an almost normal epidermis with 
similar architecture to that formed by normal adult keratinocytes, including the formation of 
basement membrane and keratinization, when transplanted on nude mice or cultured in 
organotypic culture with human dermal fibroblasts [41,42], However, the formation of normal 
tissue architecture is delayed in HaCaT transplants, indicating a reduced sensitivity to 
environmental signals compared to adult epidermal keratinocytes [41], 
It is known that similar to normal keratinocytes, HaCaT keratinocytes also express 
K1/K10 and a5 integrin [37,43], The relationship between the expression of these proteins 
and the proliferation of HaCaT keratinocytes is unexplored. It is also known that serum 
factors regulate the proliferation and differentiation of cultured human cells. The exact role of 
serum factors in the regulation of the keratinl, keratinlO and a5 integrin genes is still 
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unknown. Another marker that is expressed by suprabasal, differentiated keratinocytes is the 
mannose receptor. 
1.2 The skin and the innate immune system 
The epithelia constitutes a major barrier to the environment and provides the first line 
of defense against invading microbes. In the human epidermis keratinocytes represent a 
physical and biological protective barrier against external pathogens. Keratinocytes have been 
demonstrated to produce various kind of cytokines, and the epidermis plays an important role 
in immunologic and inflammatory responses of the body. Keratinocyte-derived cytokines are 
pivotal in mobilizing leukocytes from blood and signaling to other cutaneous cells. 
In addition to regulating immunologic and inflammatory responses, epidermal 
keratinocytes also contribute to the protective barrier of the epithelia and participate in the 
first line of defense by killing invading microorganisms. Keratinocytes have been shown to 
produce inducible antibacterial and antifungal products such as nitric oxide (NO) [44,45,46], 
antileukoprotease [48,50], LL-37 [49] and beta defensins [47,51], Keratinocyte-derived NO 
and antimicrobial peptides in the epidermis could be responsible for killing invading 
pathogens in the epidermis and preventing systemic invasion of microbes. 
Mononuclear phagocytes are believed to play an important role in combating fungal 
infections and the yeast can be internalized by macrophages though mannose receptor [52] 
which recognize mannan, the major component of Candida cell wall. 
The fact that the removal of the epidermis by scraping prior to inoculation with yeast 
results in Candida pseudohyphae invasion of the dermis also indicates that suprabasal 
keratinocytes play an important role in the defense against cutaneous Candida infection [53], 
In both experimental and naturally occurring cutaneous Candida albicans infections the 
infecting Candida albicans are confined to the upper portion of the epidermis [54,55,56]. The 
majority of the fungal cells are found among epithelial cells of the stratum corneum and they 
could not be detected in the noncornified cells of the malphigian layer [55], 
It has previously been shown that epidermal cells have direct candidacidal activity and 
this activity can be increased through stimulation of epidermal cells by UV light [57,58], a-
melanocyte stimulating hormone (a-MSH) [59] and interleukin-8 [54], IL-1, prostaglandin E2 
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(PGE2) and platelet-activating factor (PAF) has also been demonstrated to be involved in 
Candida killing by human epidermal cells [60] but the mechanism of killing remains 
unknown. 
Human squamous carcinoma cells (SCL-1) and multiply passaged epidermal 
keratinocytes from normal skin express sugar-binding proteins on their surface [61,62]. It has 
been also shown that human keratinocytes possess the ability to synthesize and express cell 
surface moieties characteristic of effector and/or accessory cells of the immune system 
[63,64], Using radioligand-binding assay with 125I-mannose-BSA we previously demonstrated 
that epidermal keratinocytes possess mannose-binding receptors on their surface (Szolnoky et 
al, in press). Immunohystological staining of normal human epidermis with polyclonal 
antibody specific for human macrophage mannose receptor showed a membrane staining on 
suprabasal keratinocytes while the staining with the monoclonal antibody raised against the 
human macrophage mannose receptor was negative. These results indicate the presence of a 
mannose binding receptor on the surface of suprabasal keratinocytes and that there is a 
homology between the putative keratinocyte and the already characterized macrophage 
mannose receptor (Szolnoky et al, in press). 
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2. AIMS 
Our aims were: 
To explore the significance of the expression of a5 integrin, keratin 1 and keratin 10 mRNAs 
and proteins in the regulation of cell proliferation and differentiation in HaCaT keratinocytes. 
To investigate the role of serum factors in the regulation of keratin 1, keratin 10 and a5 
integrin genes. 
To investigate the specific roles of D1 and D2 type cyclins in the regulation of G0/G1/S 
transition in keratinocytes. 
To demonstrate the presence of mannose binding receptors on normal human keratinocytes. 
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3. MATERIALS AND METHODS 
3.1 Cells 
3.1.1 Separation of human epidermal keratinocytes 
Human epidermal cells were obtained from healthy individuals undergoing plastic 
surgery. After removal of the subcutaneous tissue and much of the reticular dermis, the tissue 
samples were cut into small strips and incubated with dispase solution (Grade n, Roche 
Molecular Biochemicals) overnight at 4°C. Subsequently, the epidermis was peeled off from 
the dermis. The epidermis was incubated in 0.25% trypsin solution (Sigma, Csertex, Hungary) 
at 37°C for 30 minutes and aspirated using a Pasteur pipette to aid cell dissociation. The 
epidermal cell suspension was filtered through a 100 pm cell filter (BioDesign Inc. of New 
York, Carmel, NY). Epidermal cell concentration and percentage of viability was determined 
by hemocytometer. The viability of the cells was always over 95% as determined by trypan 
blue exclusion. The separated cells were characterized by immunohistochemistry on cytospin 
preparations (Cytospin, Shandon-Elliot, Frankfurt, Germany). Immunohistochemical analyzes 
demonstrated that over 95% of the separated cells were keratinocytes and the rest were 
contaminating melanocytes, no endothelial or Langerhans cells were detected. 
3.1.2 Culturing of normal human epidermal keratinocytes 
A suspension of primary epidermal cells was prepared in Keratinocyte Serum Free 
Medium (Keratinocyte-SFM, Gibco, Csertex, Hungary) supplemented with 100 U/ml 
penicillin and 100 mg/ml streptomycin (each from Gibco). Epidermal cells were seeded into 
75 cm2 tissue culture flasks (Costar, Cambridge, MA, USA) at a density of 4xl04cells/cm2 in 
Keratinocytes-SFM. Human epidermal keratinocytes were cultured in Keratinocyte-SFM in a 
humidified atmosphere containing 5% C02- The medium was changed every 2 days. 
3.1.3 Culturing of HaCaT keratinocytes 
Human HaCaT keratinocytes (kindly provided by Dr. N. E. Fusenig, Heidelberg, 
Germany) were grown in 75cm2 cell culture flasks (Costar, Cambridge, MA, USA) and 
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maintained in high glucose Dulbecco's modified Eagle's medium (high glucose DMEM, 
Gibco, Eggstein, Germany) supplemented with 10% fetal bovine serum (FBS) (Gibco), L-
glutamine, penicillin/streptomycin and fungizone (Sigma, Budapest, Hungary) at 37°C in a 
humidified atmosphere containing 5% C02- The medium was changed every 2 days. 
3.2 Synchronization procedure 
HaCaT keratinocytes were synchronized by cultivating them at high density in the 
absence of serum. Cells were grown to 100% confluence in medium containing 10% FBS for 
5 days, then the medium was replaced by serum-free high glucose DMEM. The cells were 
grown in serum free media for 1 week. The synchronized cells were trypsinized and were 
subsequently seeded into 75cm2 culture flasks at a density of 5xl03 cells/cm2 in 10% FBS 
high glucose DMEM. Samples for propidium iodide (PI) staining, reverse transcription 
polimerase chain reaction (RT-PCR) and Western blot analyzes were taken from parallel 
cultures at different times after passing the cells to the 10% FBS containing high glucose 
DMEM. 
3.3 Immunocytochemical analyzes 
3.3.1 Immunocytochemistry on cultured HaCaT keratinocytes 
Serum starved, confluent HaCaT keratinocytes were passaged into slide chambers 
(Nunc A/S, Roskilde, Denmark) at a density of 4xl04 cells/cm2 The cells were grown in these 
chambers for different times and the medium was changed every 2 days. For 
immunocytochemical staining, the cells were fixed for 20 min at 4°C in 2% 
paraformaldehyde (Sigma) then incubated overnight at 4°C in a humid chamber with the 
primary antibodies. Mouse monoclonal antibodies specific for human a5 integrin at 1:200 
dilution (Clone: SAM-1; Immunotech, Praha, Czech Republic) and mouse monoclonal 
antibodies specific for human K1 and K10 at 1:100 dilution (ICN, Budapest, Hungary) were 
used as primary antibodies. Mouse IgGl served for isotypic control staining. Immunostaining 
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was performed using an avidin-biotin immunoperoxidase kit (Vectastain Elite kit, Vector 
Laboratories, Burlingame, CA, USA) with 3-amino-9-ethylcarbazol (AEC; Sigma) as the 
chromogen. The slides were counterstained with hematoxylin. 
3.3.2 lmmunocytochemistry on cultured human epidermal melanocytes 
Separated human epidermal melanocytes were seeded (Cytospin, Shandon-Elliot, 
Frankfurt, Germany) onto glass slides. Cells were fixed in acetone (10 min, 4°C) and stained 
with the anti human MEL-5 mouse monoclonal antibody. Mel-5 is pigment-associated 
glycoprotein, which is specific for melanocytes. Mouse IgGl was used for isotypic control 
staining. The incubation step with goat the anti human MEL-5 (1:1000 dilutions) and the 
control (1:1000) for overnight at 4°C was followed with incubation of biotin-conjugated 
secondary antibodies, then streptavidin-biotin peroxidase complex using the Vectastain ABC 
kit and the instructions of the manufacturer (Vectastain Elite kit, Vector Laboratories, 
Burlingame, CA, USA). 3-amino-9-ethylcarbazole (AEC, Sigma) was used as a peroxidase 
substrate. Cells were counterstained with haematoxylin. 
3.3.3 lmmunocytochemistry on cultured human keratinocytes 
Separated keratinocytes were seeded into slide chambers (Nunc A/S, Roskilde, 
Denmark) at a density of 4xl04cells/cm2 in Keratinocyte-SFM and were maintained in a 
humidified atmosphere containing 5% C02 for different times. For immunocytochemical 
staining, the cells were fixed for 20 min at 4°C in 2% paraformaldehyde (Sigma), then 
incubated overnight at 4°C in a humid chamber with the primary antibodies. Mouse 
monoclonal antibodies specific for human cyclin D1 at 1:250 dilution (PharMingen, San 
Diego, CA, USA) and mouse monoclonal antibodies specific for human cyclin D2 at 1:250 
dilution (PharMingen, San Diego, CA, USA) were used as primary antibodies. Mouse IgGl 
served for isotypic control staining for cyclin Dl, and mouse IgG2a served for isotypic control 
staining for cyclin D2. Immunostaining was performed using an avidin-biotin 
immunoperoxidase kit (Vectastain Elite kit, Vector Laboratories, Burlingame, CA, USA) with 
3-amino-9-ethylcarbazol (AEC; Sigma) as the chromogen. The slides were counterstained 
with hematoxylin. 
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3.4 Western blot analyzes 
Total protein extracts were prepared from synchronized HaCaT cells at different times 
after the end of the synchronization process and from separated epidermal keratinocytes in a 
lysis buffer of 1.5% sodium dodecyl sulfate (SDS), 62.5 mM Tris-HCL pH 6.8, 5mM 
ethylenediamine tetraacetic acid (EDTA), 5% 2-mercaptoethanol (2-ME), lpg/ml antipain, 
lpg/ml chymostatin, and lpg/ml leupeptin (all chemicals were obtained from Sigma). Lysates 
were precleared by centrifugation and supematants were stored at -20°C. The concentration 
of proteins were defined by UV28o absorbtion. The constituent proteins of the keratinocyte 
extracts were separated by Sodium-Dodecyl-Sulphate-Polyacrylamide-Gel-Electrophoresis 
(SDS-PAGE) with 9% separating gel (SDS-PAGE) with 9% separating gel and then 
transferred to nitrocellulose membrane (Bio-Rad Laboratories, Hercules, CA, USA). In order 
to verify the equivalent loadings of proteins in the wells, the gel and the nitrocellulose were 
stained by Coomassie Brillant Blue and Ponceau S, respectively (Sigma). Membranes were 
blocked by incubation in Tris buffered saline (150 mM NaCl, 25 mM Tris pH 7.4) containing 
0.05% Tween 20 (Sigma) and 3% nonfat dry milk (Fluka Chemie AG, Neu-Buchs, 
Switzerland) for 2 hours at room temperature and subsequently incubated overnight at 4°C 
with the appropriate dilution of primary antibodies (mouse monoclonal anti-human a5 
integrin (Transcduction Laboratories) diluted 1:250, mouse monoclonal anti-human K1/K10 
(ICN) diluted 1:400 and a 1:200 dilution of goat antiserum for human MMR (kindly provided 
by Prof. Philip D. Stahl), anti human cyclin D1 and D2 (Pharmingen) diluted 1:500) in 
blocking buffer. Alkaline phosphatase conjugated goat anti-mouse IgG (Sigma) was used as 
secondary antibody at 1:2500 dilution in the blocking buffer for 2 h at room temperature. 
Blots were developed by using 5-bromo-4-chloro-3-indolyl phosphate/nitroblue tetrazolium as 
a substrate (BCIP/NBT, Sigma). 
3.5 Propidium iodide (PI) DNA analyzes 
HaCaT cells were harvested by trypsinization and washed in PBS twice. The cell 
density was adjusted to 1,5 X 10^ cells/ml then 1 ml cell suspension was centrifuged at 1000 
rpm for 10 min. The pellet was suspended in 70% cold ethanol (-20°C) and fixed for at least 
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24 hours at 4°C. Then cells were centrifuged at 3000 rpm and were suspended in 1 ml 
propidium iodide staining buffer (50pg/ml PI, and lOOU/ml RNase A, all from Sigma) and 
stained for 30 min at room temperature. The samples were analyzed using Facscalibur 
(Becton Dickinson) and Modfit (Verity Software House, Inc., Topsham, ME, USA). 
3.6 Flow cytometric analyzes of separated epidermal keratinocytes 
lxl06 freshly separated human keratinocytes were incubated with 100 ml goat anti-
human MMR antiserum dissolved in 0.5% BSA-PBS at a dilution of 1:25 for 1 h on ice. For 
isotype control preimmune goat serum was used at a dilution of 1:25. Cells were washed 
twice in PBS and incubated for another hour on ice with biotinylated mouse anti-goat IgG at 
1:200 dilution. After washing again twice in PBS cells were incubated with 100 ml 
streptavidin-PE (Becton Dickinson, Heidelberg, Germany) at 1:100 dilution for 1 h on ice. 
Cells were washed twice, then fixed in 1% paraformaldehyde and analyzed by flow cytometry 
using a FACStar Plus Flow Cytometer (Becton Dickinson). Data (10000 events per sample) 
were analyzed using the Cell Quest 3.1 F program. To investigate the trypsin sensitivity of the 
mannose binding receptors cells were incubated with 10 mg/ml trypsin (type I from bovine 
pancreas, Sigma) for 10,60 or 120 min prior to binding assay. 
3.7 Reverse transcription polimerase chain reaction (RT-PCR) 
Total RNA was isolated from lxlO6 HaCaT cells by TRIzol™ reagent (Gibco) 
following the instructions of the manufacturer. First strand cDNA was synthesized from 3 pg 
of total RNA in 20 pi final volume using a First Strand cDNA Synthesis Kit (MBI Fermentas, 
Vilnius, Lithuania). After reverse transcription, amplification was carried out by PCR reaction 
using the Taq DNA Polymerase and dNTP Set of MBI Fermentas. 10 pi of the reverse 
transcription volume was used as a template for a5 integrin specific PCR, 5 pi for 
tyrosinase0,5 pi of the reverse transcription reaction was used for K1 and K10 keratin specific 
PCR, 2pl of the reverse transcription reaction was used for cyclin D1 specific PCR and lpl of 
the reverse transcription volume was used as a template for the (3 actin specific PCR. Specific 
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primers listed in table 1 were included in the reactions at 0.66 pmol/pl final concentration. 
The PCR reactions amplified a 358 bp long product for a5 integrin, a 316 bp for keratin 1, a 
685 bp for keratin 10, a 162 bp product for cyclin Dl, 198 bp for tyrosinase and a 406 bp for 
P-actin. The same PCR conditions were used for all PCR reactions: 94 °C 90 sec., 60 °C 90 
sec., 72 °C 120 sec. The number of cycles were as follows: 35 cycles for a5 integrin, cyclin 
Dl and tyrosinase, 27 cycles for K1 and K10 keratin, and 25 cycles for P-actin. The 
concentration of MgCty was 1.5 mM in all PCR reactions. The yielding products were run on 
2% agarose gel, stained with ethydium bromide, photographed and evaluated by Kodak 
Edasl20 densitometer and Kodak ID Digital Science software and (Scientific Imaging 
Systems, New Haven, CT, USA). 
Primers Forward Reverse 
a5 integrin ATTATCAGAGCAAGAGCCGGATAGA GGAGATGAGGGACTGTAAACCGA 
Keratin 1 GGACATGGTGGAGGATTACCG TGCTCTTCTGGGCTATATCCTCG 
Keratin 10 GCAAAATCAAGGAGCGGTATGA GAGCTGCACACAGTAGCGACC 
Cyclin Dl AGGAGAACAAACAGATCA TAGGACAGGAAGTTGTTG 
Tyrosinase TTGGCAGATTGTCTGTAGCC AGGCATTGTGCATGCTGCTT 
P-actin AGAGATGGCCATGGCTGCTT ATTTGCGGTGGACGATGGAG 
3.8 Silver staining of proteins in SDS polyacrylamide gel 
A mannose binding protein was purified from human epidermal keratinocytes receptor 
by affinity chromatography on mannose coupled epoxy activated mannose-Sepharose 6B 
column (Pharmacia Biotech, Uppsala, Sweden). The purified mannose-binding protein was 
separated by Sodium-Dodecyl-Sulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
with 7.5% separating gel under non-reducing conditions. After electrophoresis, proteins were 
fixed by incubating the gel in a solution of ethanol:glacial acetic acid:water (30:10:60) for 
overnight at 4°C. Then the gel was washed in 50% ethanol and deionized water. After the last 
washing step the gel was incubated in a 0,1% solution of AgNC>3 for 30 minutes at room 
temperature. Then the gel was washed in deionized water and incubated in aqueous solution 
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of 2,5% sodium carbonate, 0,02% formaldehyde at room temperature with gentle agitation 
until stained bands of the protein appeared. The reaction was quenched by washing the gel in 
1% acetic acid. 
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4. RESULTS 
4.1. Expression of a5 integrin, keratin 1 and keratin 10 correlates with the proliferation 
of HaCaT keratinocytes 
4.1.1 Expression of a5 integrin in HaCaT keratinocytes is regulated by environmental 
conditions 
In order to achieve homogeneity of HaCaT keratinocytes the cells were synchronized. 
To avoid the use of chemical treatments, HaCaT keratinocytes were synchronized by 
cultivating the cells at high density in the absence of serum for one week. Then we forced the 
cells to re-enter the cell cycle by passing them into 10% FBS containing media. The 
expression of a5 integrin both at the mRNA and protein levels was examined at 0,12, 24, 36, 
48,72, 96 and 168h following the end of the synchronization process using RT-PCR, Western 
blot analyzes and hmnunocytochemistry. The state of the synchronized culture at different 
times was also observed by morphology (Fig. 2). A very low level of a5 integrin mRNA 
expression was detected at Oh with RT-PCR (Fig. la). The level of a5 integrin mRNA raised 
12h after release from quiescence (Fig. la) and afterwards its level gradually increased (Fig. 
la 24h, 36h) until it reached a maximum level at 48h (Fig. la). The a5 integrin mRNA level 
remained high until 96h (Fig. la). This high-level expression coincided with the intensive 
proliferation of the cells (Fig. 2). Before the culture reached confluence, the expression of a5 
integrin mRNA started to decrease (Fig. la, 168h). The level of a5 integrin protein showed a 
very similar kinetics, but as expected, the raise of the a5 mRNA preceded that of the protein. 
The a5 integrin protein was undetectable in the synchronized, serum starved cells at Oh (Fig. 
lb, Oh), then its amount started to rise gradually and reached its maximum level at 96h (Fig. 
lb). By 168h, the a5 integrin level has decreased considerably (Fig. lb). The a5 integrin 
expression was also examined by immunocytochemistry to see the differences in the 
expression among individual cells. a5 integrin was similarly expressed in all cells (Fig. 3a) 
with the exception of mitotic cells, in which a5 integrin expression appeared to be stronger 
(Fig. 3a, arrows). In the immunocytochemical analyzes, similar to the Western analyzes, the 
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a5 integrin expression was highest before the cells started to become confluent and 
afterwards, at higher cell density, the expression faded (Fig. 3b). Although one would expect a 
more distinct membrane localization, in the very active proliferative state of HaCaT cells the 
large amount of newly synthesized protein is localized to the cytoplasm (Fig. 3a). 
Interestingly, in the confluent state of the culture when the protein level is much lower (almost 
undetectable signal at 168h in the Western blot analyzes; Fig. lb) one could clearly see the 
membrane localization of the protein (Fig. 3b). 
Time (h) 0 12 24 36 48 72 96 168 
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Figure 1. a5 integrin expression in HaCaT keratinocytes after release from quiescent state. 
The expression of a5 integrin was analyzed by RT-PCR (a) and by Western blot analyzes (b) 
at the times indicated after releasing the cells from serum starvation and contact inhibition. 
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Figure 2. Morphological changes in the synchronized HaCaT culture different times after 
release from cell quiescence. 
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Figure 3. Immunocytochemical staining of HaCaT keratinocytes for a5 integrin and K1/K10 
at different times after release from cell quiescence. 36 h after serum addition and passage all 
cells in the culture show a5 integrin staining (a). Mitotic cells in the culture (arrows) appear to 
have a stronger a5 integrin expression relative to the other cells (a). Later, when the cells 
reach higher density, the a5 integrin expression decreases in the cells (b). HaCaT 
keratinocytes stain strongly for K1 and K10 shortly after release from cell quiescence (c). 
Later, in the more confluent culture, the expression of K1 and K10 decreases. Bar = 50pm. 
4.1.2 HaCaT keratinocytes lose K1/K10 expression after release from synchronized state 
The expression of K1/K10 was examined in the same system. Both K1 and K10 
mRNAs were highly expressed in the synchronized, serum depleted and contact inhibited 
HaCaT keratinocytes (Fig. 4a, Oh). After release from quiescence, the level of K1 and K10 
mRNAs decreased dramatically. A very low level of K1 mRNA was still detectable at 
12h in the culture, but the mRNA level of keratin 10 became undetectable in the 12h sample. 
K1 and K10 mRNAs were undetectable after the 12h (Fig. 4a). Changes in the levels of K1 
and K10 proteins were followed by Western blot analyzes. K1 and K10 proteins were present 
in the cells in extremely large amounts in the synchronized, serum depleted culture (Fig. 4b, 
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Oh). Afterwards both K1 and K10 protein levels started to decrease very slowly (Fig. 4b, 12h, 
24h, 36h, 48h, 72h), but were still high even 72h after the end of synchronization, despite the 
apparent lack of new protein synthesis during this period. K1 protein became undetectable by 
96 h (Fig. 4b), at the same time K10 protein was still detectable even in the 168h sample (Fig. 
4b), although its amount has decreased considerably. The expression of K1/K10 keratins were 
also examined by immunocytochemistry to make certain that the decrease in the levels of 
K1/K10 proteins detected by Western analyzes was not due to differential expression by a 
subpopulation of cells within the culture. Individual cells did not show differences in K1/K10 
expression and the expression kinetics observed by immunocytochemistiy was very similar to 
the Western analyzes. The level of K1/K10 proteins decreased dramatically from the initial 
high level (Fig. 3c) to a very low level as the culture moved toward confluence (Fig. 3d). The 
above-described kinetics of K1/K10 mRNA and protein expressions in HaCaT cells indicate 
that both keratin types are very long-lived proteins. In fact there is no evidence in normal 
keratinocytes that K1/K10 once synthesized could disappear from the cells. The ability to 
degrade K1/K10 may be a special characteristic of HaCaT keratinocytes and could be a key 
function in their immortality. 
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Figure 4. K1 and K10 expression in HaCaT keratinocytes after release from cell quiescence. 
Changes in the expression of K1/K10 mRNAs were analyzed by RT-PCR (a), K1/K10 
proteins were analyzed by immunoblotting (b) at the times indicated after release from cell 
quiescence. 
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4.1.3 a5 integrin mRNA and protein expression increase while keratin 1 and 10 mRNAs 
and protein decrease dramatically with proliferation in HaCaT keratinocytes 
D1 cyclin mRNA expression and DNA staining with PI were used to follow the 
proliferation state of the synchronized HaCaT cells after release from contact inhibition and 
serum starvation. Cyclin D1 is an early G1 phase marker [65]. After 1 week of serum 
starvation the cells had undergone an almost complete cell cycle withdrawal. At Oh both the 
cyclin D1 mRNA (Fig. 5) and the number of S/G2/M phase cells (Fig. 6a) were very low in 
the culture and they both remained at low level during the first 24h after release from 
quiescence. A gradual increase in cyclin D1 message was detected between 24 and 72h (Fig. 
5) that was closely followed by an increasing number of cells entering S phase (Fig. 6), 
indicating a high rate of proliferation among the cells by day 3. K1/K10 mRNAs decreased to 
undetectable levels between 24 and 48h (Fig. 6b). Although the cells still contained high 
levels of K1/K10 proteins, there was a substantial relative decrease for both keratins by day 3 
(24,3% for K1 and 46,2% for K10, Fig. 6c). A dramatic increase in a5 integrin mRNA 
preceded the high level proliferation of the cells at 24 h (Fig. 6b), that was followed by a 
gradual increase in a5 integrin protein expression (Fig. 6c). The increase in the amount of a5 
integrin protein paralleled the increase in the number of S/G2/M phase cells (Fig. 6a and c), 
indicating a close connection between a5 integrin protein expression and cell proliferation. 
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Figure 5. The expression of cyclin D1 mRNA in HaCaT keratinocytes after release from cell 
quiescence. 
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Figure 6. Comparison of cell proliferation and the expression of a5 integrin, K1 and K10 in 
HaCaT cells. 
4.1.4 The roles of cyclin D1 and D2 are different in human keratinocytes 
To establish whether keratinocytes in different stages of differentiation require 
different subsets of these complexes, we analyzed the expression of cyclin D1 and D2 in 
cultured keratinocytes. Freshly separated human epidermal keratinocytes from healthy adults 
were seeded onto slide flasks. Previously it was demonstrated that cultured human 
keratinocytes represented the K1/K10- basal cells 24 hours after seeding, which entered the 
Gl/S phase from GO quiescent state (G0/G1/S transition). 72 hours after seeding, cultured 
keratinocytes have completed the first cell division and entered the next Gl/S phase (they 
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represented the transiently amplifying cells within the epidermis [19]. Immunocytochemical 
staining was performed on the cultured keratinocytes 24 and 72 hours after seeding with 
monoclonal anti human cyclin D1 and D2 antibodies. We found that 24 hours after seeding 
when keratinocytes entered the cell cycle from quiescence (GO phase), cells showed a positive 
nuclear staining for cyclin D1 (Fig. 7a) but not for cyclin D2. 72 hours after seeding, 
proliferating keratinocytes that entered from G1 but not from GO into S phase, showed a 
positive nuclear staining for cyclin D2 (Fig. 7b) but not for cyclin Dl, indicating a different 
role for Dl and D2 cyclins in the regulation of cell cycle progression. Interestingly, in some of 
the cells cyclin D2 showed cytoplasmic staining (Fig. 7c) which was never observed for cyclin 
Dl . 
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Figure 7. Immunocytochemical staining of cultured human keratinocytes for cyclin Dl (a) 
and D2 (b and c) at different times after seeding. 
4.1.5 Expression of cyclin Dl and D2 in cultured human epidermal melanocytes 
To investigate whether the differential expression of D-type cyclins is typical only to 
keratinocytes or also to other cell types, the expression of cyclin Dl and D2 was investigated 
in human epidermal melanocytes with Western analyzes. We found that cyclin Dl was 
predominantly expressed in proliferating melanocytes in every passages although cyclin D2 
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protein expression was also observed in a much less extent. (Fig. 8) 
To gain melanocytes epidermal cell suspension was seeded onto tissue culture flasks. 
The primary cell culture still contained both keratinocytes and melanocytes. Keratinocytes 
were progressively removed from the culture during culturing and pure melanocyte cultures 
were obtained. This separation is based on the different attachment characteristics of 
keratinocytes and melanocytes to the culture plastic flask. Trypsin treatment release 
melanocytes 2-3 minutes earlier than keratinocytes from attachment to the tissue culture 
plastic, thus enabling separation of the two cell populations. Melanocytes were identified by 
morphological characteristics, tyrosinase mRNA expression and a melanin-associated 
glycoprotein (MEL-5) expression that were performed on melanocytes at different passage 
numbers (Fig. 9). 
The expression of tyrosinase is a specific marker of melanocytes. Expression of the 
tyrosinase gene in cultured cells was examined by RT-PCR (Fig. 9c). The results showed that 
cells expressed tyrosinase mRNA at high level up to the 10th passage, confirming their 
melanocyte origin. In subsequent cultures the expression of tyrosinase started to decrease to a 
very low level (Fig. 9c). Cultured cells showed typical melanocyte morphology (Fig. 9a) and 
were positively stained with MEL-5 antibody (Fig. 9b) verifying their melanocyte origin. The 
MEL-5 staining was detectable usually up to the 5th passage, showing a good correlation with 
the presence of melanin in the cells. As it was expected, the expression of tyrosinase and the 
positive staining with MEL-5 showed a correlation with the pigment content of cultured 
melanocytes. 
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Figure 8. Expression of cyclin D1 and D2 proteins was analyzed by Western blot analyzes in 
proliferating epidermal melanocytes in different passages. 
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Figure 9 Identification of melanocytes. Cultured cells showed dendritic or spindle-like 
morphology, which is typical for melanocytes (a). Cultured cells were positively stained with 
melanocyte-specific antibody MEL-5 (b). Melanocytes expressed tyrosinase mRNA up to the 
13th passage (c). 
4.2, Serum factors regulate the expression of keratin 1 and a5 integrin genes but not the 
keratin 10 gene in HaCaT keratinocytes 
To see whether the dramatic down-regulation of K1/K10 gene expression and the 
significant up-regulation of a5 integrin mRNA expression were driven by serum factors or 
contact inhibition, RT-PCR analyzes was used. The effect of serum deprivation was examined 
on freshly seeded HaCaT cells to exclude the effects of contact inhibition on the expression of 
these genes. These cells were not starved and synchronized prior to seeding. Seeding was 
performed in the presence of serum and the cells were kept in the serum-supplemented media 
for 12h before serum withdrawal. 12h after seeding, only a very low level of K1 and K10 
expression could be detected in the cells (Fig. 10, 12h). 24h after serum withdrawal, HaCaT 
keratinocytes showed a dramatic increase in K1 mRNA expression (Fig. 10, 36h), suggesting 
a strong suppression of the K1 gene by serum factors. Later, at 48 and 72h after serum 
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withdrawal, the expression of K1 mRNA decreased gradually (Fig. 10, 60 and 84h), indicating 
that additional regulatory mechanisms also exist. Surprisingly, the K10 mRNA level remained 
unchanged upon serum withdrawal (Fig. 10), indicating that the expression of keratin 10 gene 
is not regulated by serum factors. A relatively strong a5 integrin mRNA expression was found 
at 12h in the culture in the presence of serum (Fig. 10, 12h). After removal of the serum from 
the culture media, the a5 integrin mRNA expression decreased to an almost undetectable level 
(Fig. 10, 36, 60h), suggesting that serum factors regulate the a5 integrin gene expression. 72h 
after serum withdrawal the expression of a5 integrin mRNA reappeared in the cells (Fig. 10, 
84h), indicating that beside serum factors other regulatory mechanisms also exist. 
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Figure 10. Effect of serum withdrawal on the expression of a5 integrin and K1/K10 mRNAs 
in HaCaT keratinocytes (RT-PCR). 
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4.3. Further characterization of the mannose binding receptors expressed on suprabasal 
human keratinocytes 
4.3.1. Flow cytometric detection of mannose receptors on the surface of separated 
epidermal keratinocytes 
To demonstrate that epidermal keratinocytes express mannose-binding receptors on 
their surface, freshly separated human epidermal keratinocytes were stained with the goat 
polyclonal sera raised against the human macrophage mannose receptor and analyzed by flow 
cytometer. Since it is known that macrophage mannose receptor is sensitive to proteolysis we 
aimed to determine the trypsin-sensitivity of keratinocyte mannose receptor and its recovery 
after trypsinization. A preliminary experiment with radiolabelled mannose-BSA showed that 
keratinocyte mannose receptor was sensitive to proteolysis (Szolnoky et al, in press). To 
explore the time kinetic of the recovery of mannose receptors after trypsinization, freshly 
separated keratinocytes were incubated in PBS at 37°C for 10, 30, 60 and 120 min after 
trypsin exposure. Both the ratio of positive cells and the AMCF (A -mean channel 
fluorescence = mean channel fluorescence of cells stained with the goat immune serum minus 
mean channel fluorescence of cells stained with non-immune goat serum) showed a rapid, 
time-dependent increase in mannose receptor expression on keratinocytes. After the shortest 
incubation (10 min), 32.5% of the cells already showed positive staining (Fig. 11) relative to 
the isotype control and the AMCF was 8.36, indicating that mannose receptors on 
keratinocytes can recover very rapidly after trypsinization. As a result of prolonged incubation 
we detected a time-dependent increase in both the number of mannose receptor positive cells 
(Fig. 11; 30 min: 49.38%, 60 min: 56.18%, 120 min: 65.81%) and in AMCF (30 min: 12.47, 
60 min: 14.08,120 min: 17.05). 
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Figure 11. Recovery of keratinocyte mannose receptor after trypsinization. 
4.3.2 Western blot analyzes of the keratinocyte mannose binding receptor 
Western blot analyzes was also used to demonstrate the presence of the mannose 
binding receptor on separated epidermal keratinocytes and on the immortalized human 
keratinocyte cell line HaCaT. On Western blots of human keratinocyte and HaCaT cell 
extracts the polyclonal goat anti-human MMR antibody stained a band with a molecular 
weight of approximately 200 kD both in normal keratinocytes and HaCaT cells (Fig. 12). 
KC HaCaT 
200kD 
Figure 12. Western blot analyzes of keratinocyte mannose receptor on normal human 
keratinocytes and HaCaT cells. 
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4.3.3 Silver staining of affinity purified mannose receptor 
In order to further characterize the keratinocyte mannose receptor we isolated the 
receptor by affinity chromatography on mannose-Sepharose column from human keratinocyte 
extract. The eluted protein was concentrated and separated by Sodium-Dodecyl-Sulphate-
Polyaciylamide-Gel-Electrophoresis (SDS-PAGE). The protein band visualized by silver 
staining revealed a single band at approximately 200 kD (Fig. 13). 
Mw KMR 
200kD-> 
Figure 13. Silver staining of affinity purified keratinocyte mannose receptor. 
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5. DISCUSSION 
The skin is a protective barrier against the external environment. The uppermost layer 
of the skin is the epidermis, which is a continuously renewing tissue. The most abundant cell 
type in the epidermis is the keratinocyte. Terminally differentiated corneocytes provide a 
mechanical barrier, while suprabasal keratinocytes are able to accomplish immunological 
functions as killing invading microorganisms and alert other immune components in the skin. 
In the epidermis only the innermost basal layer of keratinocytes has proliferative capacity that 
makes the epidermis renewing by replacing the continuously loosening corneocytes. Under a 
yet unidentified trigger of terminal differentiation, a basal keratinocyte stem cell undergoes a 
series of morphological and biochemical changes as it becomes a fully differentiated 
corneocyte. 
In the present work we investigated two interesting aspects of the human epidermis: 
regulation of differentiation and proliferation of human keratinocytes and the molecular basis 
of immunological role of keratinocytes. For investigating the keratinocyte differentiation 
markers in vitro, we developed a model. In this model, proliferation and differentiation 
markers of synchronized HaCaT keratinocytes could be investigated in vitro, without the use 
of chemical treatments. With changing the environmental conditions of cultured cells, we 
could differentiate them and then induce their de-differentiation. This model provides a tool 
for investigating epidermal keratinocytes in different states of differentiation and 
proliferation. 
In order to better understand the proliferation and differentiation processes of 
keratinocytes, we have chosen molecular markers that are characteristics for specific 
keratinocyte populations. Analyzes of the expression of a5 integrin, K1/K10, and the 
proliferation state of the synchronized HaCaT cell cultures revealed a close correlation 
between the proliferation of HaCaT cells and the expression of a5 integrin both at the rriRNA 
and protein levels. The a5 integrin mRNA expression precedes and the a5 integrin protein 
expression coincides with the intensive proliferation of the cells, defined by the expression of 
cyclin Dl, an early G1 marker, and PI DNA analyzes. These facts suggest that a5 integrin 
may play a role in the promotion of HaCaT proliferation. This finding is not surprising, since 
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increased expression of a5 integrin on keratinocytes in the in vivo epidermis is associated 
with hyperproliferation of the cells [13,66], The in vivo significance of a5 integrin expression 
and function in the epidermis have been demonstrated by forced suprabasal expression of a5 
integrin of transgenic mice that resulted in a phenotype reminiscent of the hyperproliferative 
skin disease, psoriasis [67], 
As opposed to a5 integrin, the down-regulation of K1/K10 at the niRNA level seems 
to be a prerequisite for proliferation of HaCaT cells, indicating an inhibitory role for these 
keratins in proliferation. Although at the time of intensive proliferation K1/K10 proteins were 
still present in the cells, new proteins could not be synthesized, since no mRNA was present 
for these keratin types. It is possible that a continuous synthesis of keratins are required to 
block cell proliferation. The newly synthesized keratins may differ from the already existing 
keratins in various functions such as inhibition of proliferation. Changes in keratin functions 
may be due to posttranslational modifications occurring during differentiation of 
keratinocytes, as it was shown by Fuchs et al. [6]. Together with actin microfilaments and 
microtubules, keratin filaments make up the cytoskeleton of epithelial cells. Although these 
proteins are thought to be involved in maintaining the mechanical integrity of epithelial cells, 
their function in the complex differentiation process is still unclear. It was shown that ectopic 
expression of K10 inhibits the proliferation of HaCaT cells in culture [23], 
Our results also indicate that the expression of K1 gene is tightly regulated by serum 
factors and the K1 and K10 genes are regulated differentially. Although it has been previously 
reported that the expression of K1 and K10 could be regulated independently, the background 
of this differential regulation was not clarified [37], Based on the results of our experiments 
we conclude that the expression of K1 is regulated by serum factors, but other regulatory 
mechanisms also exist. On the other hand, serum factors seem to have no direct regulatory 
effect on K10 gene expression. 
The expression of a5 integrin is linked to an undifferentiated, intensively proliferating 
state of HaCaT keratinocytes and a5 integrin is expressed in an opposite way to the K1/K10 
keratins. This is similar to the expression of a5 integrin in normal human keratinocytes in 
which a.5 integrin expression coincides with a highly proliferative, undifferentiated state of 
the cells [10], 
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We found a strong expression of a5 integrin in HaCaT cells growing in the presence 
of serum that decreased dramatically after the removal of serum from the culture media, 
indicating that serum factors have a role in the regulation of a5 integrin gene expression. This 
finding may be relevant to the situation of wound healing where keratinocytes are exposed to 
serum factors, that could be responsible for the induction of a5 integrin expression on 
keratinocytes in the wound. One important factor present in the serum, that is known to 
regulate a5 integrin expression in various cells is fibronectin [7,13,68-70]. 
HaCaT keratinocytes under serum free, contact inhibited conditions with the strong 
expression of K1/K10 and the suppressed expression of a5 integrin resemble the suprabasal, 
non-proliferating keratinocytes of normal human in vivo epidermis. It is possible that serum 
factors that are able to diffuse through the basement membrane from the dermis into the 
epidermis regulate the expression of K1 in the in vivo epidermis. As keratinocytes move 
away from the basement membrane, the concentration of these membrane-diffusable serum 
factors gradually decrease and the cells start to express Kl. However, in normal keratinocytes 
there is no evidence that the expression of Kl and K10 could be reversed. The ability of 
HaCaT cells to dedifferentiate seems to be a unique feature of these cells and maybe related 
to their immortalized nature [37], 
Our data support previous investigations describing similarities between HaCaT cells and 
normal keratinocytes and concluding that HaCaT cells are excellent candidates for studying 
external regulators of proliferation and differentiation and the underlying molecular 
mechanisms [37]. Our findings also emphasize the importance of the in vitro culture 
conditions of the cells. HaCaT keratinocytes under different conditions represent different 
types of keratinocytes. In the serum starved, contact inhibited culture HaCaT cells resemble 
the suprabasal, non-proliferating, differentiated (K1/K10+) keratinocytes of normal 
epidermis, while the highly proliferative HaCaT cells (a5 integrin+, K1/K10+) after release 
from contact inhibition and addition of serum resemble the activated (a5 integrin+), 
differentiated (K1/K10+), transiently amplifying keratinocytes. 
As a result of recent studies, the cyclin dependent kinase complex has come to be 
taken up as a target of proliferation and carcinogenesis of keratinocytes. Cyclins Dl, D2 and 
D3 are thought to function in the G1 phase of the cell division cycle by regulating the activity 
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of cyclin-dependent protein kinases. All three D-type cyclins can be shown to associate with 
two specific kinases, CDK4 and CDK6 and to bind to retinoblastoma protein (Rb), providing 
at least six possible combinations [71]. To establish whether keratinocytes in different stage 
of differentiation require different subsets of these complexes, we analyzed the expression of 
cyclin D1 and D2 in keratinocytes. We showed that not only the differentiation and immune 
associated markers change their expression pattern during this process, but also important cell 
cycle regulators, cyclin D1 and D2. We hypothesize that basal epidermal keratinocyte stem 
cells when enter into the cell cycle express cyclin D1 but not D2 in early G1 phase. The 
proliferating transiently amplifying keratinocytes that are committed to differentiation express 
cyclin D2 but not cyclin D1 for Gl/S transition. As cyclin D1 and cyclin D2 phosphorilate the 
Rb protein differentially, the different D type cyclins may have different effects on gene 
regulation and cell proliferation. The difference may be associated with the different 
functions and fate of keratinocytes in the epidermis. To explore that differential use of typel 
and type 2 D cyclins is a unique feature of keratinocytes or typical for other cell types in the 
epidermis, we investigated the expression of D-type cyclins in cultured epidermal 
melanocytes. Similarly to keratinocytes melanocytes also use these cyclins differentially 
during the cell cycle progression. 
We showed the presence of a mannose binding receptor on the surface of suprabasal 
epidermal keratinocytes. This finding also demonstrates that epidermis is not only passive 
physical barrier but an active immune organ. In this immune organ epidermal keratinocytes 
are able to kill invading pathogens and prevent their systemic invasion by producing nitric 
oxide and antimicrobial peptides. The fact that the polyclonal antibody raised against the 
human macrophage mannose receptor (hMMR) is able to recognize keratinocyte mannose 
receptor (KMR) indicates a homology between the two receptors. However, the monoclonal 
anti-human macrophage mannose receptor antibody does not recognize the keratinocyte 
mannose receptor. This finding indicates that the two receptors are not identical. We showed 
that the mass of the keratinocyte mannose binding protein is approximately 200 kD while the 
mass of the macrophage mannose receptor is around 175 kD. We also compared the trypsin 
sensitivity of the macrophage and keratinocyte mannose receptor. Similarly to the 
macrophage mannose receptor, the keratinocyte mannose receptor is also sensitive to 
trypsinization (Szolnoky et al., in press). In the case of macrophage mannose receptor it was 
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shown that removal of surface expressed MMR activity by trypsin incubation at 4°C was 
followed by a fast (10 min) recovery of the receptor activity at 37°C suggesting the existence 
of an intracellular pool of receptors [72], We determined that the recovery of keratinocyte 
MR after trypsinization is also a rapid process, as in the case of macrophage MR. 
Using affinity chromatography on Mannose-Sepharose column from keratinocyte cell 
extract, we isolated a singular protein with a molecular weight of ~200 kD. Since the 
molecular weight of macrophage mannose receptor is only -175 kD this result together with 
the finding that the polyclonal anti MMR serum but not the monoclonal anti MMR could 
recognize the KMR in the epidermis suggest that KMR is homologus but not identical to 
MMR. Using Western analyzes with the polyclonal anti human macrophage mannose receptor 
antibody a specific band was found with an apparent molecular weight of 200 kD. 
Based on our data (Szolnoky et al., in press), keratinocyte macrophage mannose 
receptor does not mediate phagocytosis of pathogens and the mechanism of killing invading 
microorganism may be different in keratinocytes and macrophages. In rat neutrophils, nitric 
oxide (NO) was shown to be involved in the candidacial activity [73], Since human 
keratinocytes are also able to express inducible nitric oxide synthase (iNOS) NO is likely to 
act as a key component in the first line of defense in the skin. Our group has demonstrated 
that NO produced by keratinocytes also plays a crucial role in the Candida killing 
mechanism. Freshly separated keratinocytes isolated from iNOS knockout mice were not able 
to kill Candida albicans, while the keratinocytes isolated from wild-type mice show 
Candidacial activity like human keratinocytes (unpublished results). We hypothesize that 
keratinocyte mannose receptor may be involved in the induction of the expression of iNOS by 
invading pathogens. The activation of mannose receptor may result in the activation of iNOS 
gene expression and NO production. The production of NO by epidermal keratinocytes could 
be responsible for killing various bacteria, and fungi, which have been shown to be sensitive 
to NO such as Candida albicans, Mycobacterium tuberculosis and Escherichia coli [74], 
Recently, several broad spectrum microbicidal molecules have been identified in 
mammalian epithelium that are inducible or expressed constitutively. Numerous studies have 
reported that the source of antimicrobial peptides is the epidermal keratinocyte [48,49]. LL-37 
antibacterial peptide was shown to be inducible [49], while antileukoprotease is constitutively 
produced in human keratinocytes. Human beta defensin-2 and 3 are inducible, 
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transcriptionally regulated antimicrobial peptides expressed by keratinocytes. 
It is possible that the invading pathogens in the epidermis can induce the production of 
antimicrobial factors in keratinocytes such as NO, LL-37 and defensins through the 
keratinocyte mannose receptor. The role of KMR in the epidermal host defense is indirectly 
suggested by the fact that the place of production of keratinocyte-derived antimicrobial 
factors is the suprabasal layer of the epidermis, the same where the KMR is expressed 
[48,49], The finding that epidermal keratinocytes express KMR also demonstrates that the 
epidermis is not only a passive physical barrier but functions as an active immune organ. In 
this organ suprabasal keratinocytes are able to kill invading microbes by producing 
antimicrobial factors and thereby prevent infections. 
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6. SUMMARY 
1. We have developed a model using the immortalized HaCaT keratinocytes, for 
investigating markers that are associated with differentiation and proliferation of 
keratinocytes. 
2. We have obtained data suggesting that a5 integrin, keratin 1 and keratin 10 proteins are 
not only markers of proliferation and differentiation of HaCaT keratinocytes, but 
important regulators of these processes. 
3. We have shown that serum factors and cell density regulate the process of keratinocyte 
proliferation and differentiation (possibly besides other pathways) through the regulation 
of the mRNA and protein expression of these genes. 
4. Our results suggest that cyclin D1 and cyclin D2 have different functions in human 
keratinocytes. Cyclin D1 expression is specific for G0/G1/S transition when quiescent 
keratinocytes enter the cell cycle, while cyclin D2 regulates the Gl/S transition of already 
proliferating keratinocytes. 
5. We have demonstrated the presence of a mannose receptor on the surface of keratinocytes 
and started its molecular characterization. The keratinocyte mannose receptor has a 
molecular weight of ~200 kD and indirect evidences suggest that it is homologous but not 
identical to the macrophage mannose receptor. 
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